Article info
PDFPulmonary vascular disease
Original article
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
- Correspondence to Dr Nick H Kim, Division of Pulmonary and Critical Care Medicine, University of California, San Diego, 9300 Campus Point Drive, MC 7381, La Jolla, CA 92037, USA; h33kim{at}ucsd.edu
Citation
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
Publication history
- Received March 9, 2016
- Revised September 14, 2016
- Accepted September 19, 2016
- First published December 23, 2016.
Online issue publication
January 18, 2021
Article Versions
- Previous version (24 July 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/